Healthcare Specialty Enzymes Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2020 - 2027

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Healthcare Specialty Enzymes Market, By Product Type

7.1.  Healthcare Specialty Enzymes Market, By Product Type, 2020-2030

7.1.1.    Carbohydrases

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Polymerases and Nucleases

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Proteases

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    Lipases

7.1.4.1.        Market Revenue and Forecast (2016-2030)

7.1.5.    Phosphatases/Phytases

7.1.5.1.        Market Revenue and Forecast (2016-2030)

7.1.6.    Other Products

7.1.6.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Healthcare Specialty Enzymes Market, By Enzymes Source Type

8.1.  Healthcare Specialty Enzymes Market, By Enzymes Source Type, 2020-2030

8.1.1.    Micro-organisms

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Animals

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Plants

8.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Healthcare Specialty Enzymes Market, By Enzymes Technique Type

9.1.  Healthcare Specialty Enzymes Market, By Enzymes Technique Type, 2020-2030

9.1.1.    Clinical Chemistry

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Immunodiagnostics/Immunoassays

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Molecular Diagnostics

9.1.3.1.        Market Revenue and Forecast (2016-2030)

9.1.4.    Hematology

9.1.4.1.        Market Revenue and Forecast (2016-2030)

9.1.5.    Microbiology

9.1.5.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Healthcare Specialty Enzymes Market, By Usage Type

10.1.        Healthcare Specialty Enzymes Market, By Usage Type, 2020-2030

10.1.1.  Research & Biotechnology

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Diagnosis

10.1.2.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Healthcare Specialty Enzymes Market, By Application

11.1.        Healthcare Specialty Enzymes Market, By Application, 2020-2030

11.1.1.  Infectious disease

11.1.1.1.      Market Revenue and Forecast (2016-2030)

11.1.2.  Diabetes

11.1.2.1.      Market Revenue and Forecast (2016-2030)

11.1.3.  Oncology

11.1.3.1.      Market Revenue and Forecast (2016-2030)

11.1.4.  Cardiology

11.1.4.1.      Market Revenue and Forecast (2016-2030)

11.1.5.  Nephrology

11.1.5.1.      Market Revenue and Forecast (2016-2030)

11.1.6.  Autoimmune diseases

11.1.6.1.      Market Revenue and Forecast (2016-2030)

Chapter 12.      Global Healthcare Specialty Enzymes Market, By End-use

12.1.        Healthcare Specialty Enzymes Market, By Enzymes Source Type, 2020-2030

12.1.1.  Hospitals

12.1.1.1.      Market Revenue and Forecast (2016-2030)

12.1.2.  Laboratory

12.1.2.1.      Market Revenue and Forecast (2016-2030)

12.1.3.  Others

12.1.3.1.      Market Revenue and Forecast (2016-2030)

Chapter 13.      Global Healthcare Specialty Enzymes  Market, Regional Estimates and Trend Forecast

13.1.        North America

13.1.1.  Market Revenue and Forecast, By Product (2016-2030)

13.1.2.  Market Revenue and Forecast, By Enzymes Source (2016-2030)

13.1.3.  Market Revenue and Forecast, By Enzymes Technique (2016-2030)

13.1.4.  Market Revenue and Forecast, By Usage (2016-2030)

13.1.5.  Market Revenue and Forecast, By Application (2016-2030)

13.1.6.  Market Revenue and Forecast, By End-use (2016-2030)

13.1.7.  U.S.

13.1.7.1.      Market Revenue and Forecast, By Product (2016-2030)

13.1.7.2.      Market Revenue and Forecast, By Enzymes Source (2016-2030)

13.1.7.3.      Market Revenue and Forecast, By Enzymes Technique (2016-2030)

13.1.7.4.      Market Revenue and Forecast, By Usage (2016-2030)

13.1.8.  Market Revenue and Forecast, By Application (2016-2030)

13.1.8.1.      Market Revenue and Forecast, By End-use (2016-2030)

13.1.9.  Rest of North America

13.1.9.1.      Market Revenue and Forecast, By Product (2016-2030)

13.1.9.2.      Market Revenue and Forecast, By Enzymes Source (2016-2030)

13.1.9.3.      Market Revenue and Forecast, By Enzymes Technique (2016-2030)

13.1.9.4.      Market Revenue and Forecast, By Usage (2016-2030)

13.1.10.               Market Revenue and Forecast, By Application (2016-2030)

13.1.11.               Market Revenue and Forecast, By End-use (2016-2030)

13.1.11.1.    

13.2.        Europe

13.2.1.  Market Revenue and Forecast, By Product (2016-2030)

13.2.2.  Market Revenue and Forecast, By Enzymes Source (2016-2030)

13.2.3.  Market Revenue and Forecast, By Enzymes Technique (2016-2030)

13.2.4.  Market Revenue and Forecast, By Usage (2016-2030)

13.2.5.  Market Revenue and Forecast, By Application (2016-2030)

13.2.6.  Market Revenue and Forecast, By End-use (2016-2030)

13.2.7.   

13.2.8.  UK

13.2.8.1.      Market Revenue and Forecast, By Product (2016-2030)

13.2.8.2.      Market Revenue and Forecast, By Enzymes Source (2016-2030)

13.2.8.3.      Market Revenue and Forecast, By Enzymes Technique (2016-2030)

13.2.9.  Market Revenue and Forecast, By Usage (2016-2030)

13.2.10.               Market Revenue and Forecast, By Application (2016-2030)

13.2.10.1.   Market Revenue and Forecast, By End-use (2016-2030)

13.2.11.               Germany

13.2.11.1.   Market Revenue and Forecast, By Product (2016-2030)

13.2.11.2.   Market Revenue and Forecast, By Enzymes Source (2016-2030)

13.2.11.3.   Market Revenue and Forecast, By Enzymes Technique (2016-2030)

13.2.12.               Market Revenue and Forecast, By Usage (2016-2030)

13.2.13.               Market Revenue and Forecast, By Application (2016-2030)

13.2.14.               Market Revenue and Forecast, By End-use (2016-2030)

13.2.14.1.    

13.2.15.               France

13.2.15.1.   Market Revenue and Forecast, By Product (2016-2030)

13.2.15.2.   Market Revenue and Forecast, By Enzymes Source (2016-2030)

13.2.15.3.   Market Revenue and Forecast, By Enzymes Technique (2016-2030)

13.2.15.4.   Market Revenue and Forecast, By Usage (2016-2030)

13.2.16.               Market Revenue and Forecast, By Application (2016-2030)

13.2.16.1.   Market Revenue and Forecast, By End-use (2016-2030)

13.2.17.               Rest of Europe

13.2.17.1.   Market Revenue and Forecast, By Product (2016-2030)

13.2.17.2.   Market Revenue and Forecast, By Enzymes Source (2016-2030)

13.2.17.3.   Market Revenue and Forecast, By Enzymes Technique (2016-2030)

13.2.17.4.   Market Revenue and Forecast, By Usage (2016-2030)

13.2.18.               Market Revenue and Forecast, By Application (2016-2030)

13.2.18.1.   Market Revenue and Forecast, By End-use (2016-2030)

13.3.        APAC

13.3.1.  Market Revenue and Forecast, By Product (2016-2030)

13.3.2.  Market Revenue and Forecast, By Enzymes Source (2016-2030)

13.3.3.  Market Revenue and Forecast, By Enzymes Technique (2016-2030)

13.3.4.  Market Revenue and Forecast, By Usage (2016-2030)

13.3.5.  Market Revenue and Forecast, By Application (2016-2030)

13.3.6.  Market Revenue and Forecast, By End-use (2016-2030)

13.3.7.  India

13.3.7.1.      Market Revenue and Forecast, By Product (2016-2030)

13.3.7.2.      Market Revenue and Forecast, By Enzymes Source (2016-2030)

13.3.7.3.      Market Revenue and Forecast, By Enzymes Technique (2016-2030)

13.3.7.4.      Market Revenue and Forecast, By Usage (2016-2030)

13.3.8.  Market Revenue and Forecast, By Application (2016-2030)

13.3.9.  Market Revenue and Forecast, By End-use (2016-2030)

13.3.10.               China

13.3.10.1.   Market Revenue and Forecast, By Product (2016-2030)

13.3.10.2.   Market Revenue and Forecast, By Enzymes Source (2016-2030)

13.3.10.3.   Market Revenue and Forecast, By Enzymes Technique (2016-2030)

13.3.10.4.   Market Revenue and Forecast, By Usage (2016-2030)

13.3.11.               Market Revenue and Forecast, By Application (2016-2030)

13.3.11.1.   Market Revenue and Forecast, By End-use (2016-2030)

13.3.12.               Japan

13.3.12.1.   Market Revenue and Forecast, By Product (2016-2030)

13.3.12.2.   Market Revenue and Forecast, By Enzymes Source (2016-2030)

13.3.12.3.   Market Revenue and Forecast, By Enzymes Technique (2016-2030)

13.3.12.4.   Market Revenue and Forecast, By Usage (2016-2030)

13.3.12.5.   Market Revenue and Forecast, By Application (2016-2030)

13.3.12.6.   Market Revenue and Forecast, By End-use (2016-2030)

13.3.13.               Rest of APAC

13.3.13.1.   Market Revenue and Forecast, By Product (2016-2030)

13.3.13.2.   Market Revenue and Forecast, By Enzymes Source (2016-2030)

13.3.13.3.   Market Revenue and Forecast, By Enzymes Technique (2016-2030)

13.3.13.4.   Market Revenue and Forecast, By Usage (2016-2030)

13.3.13.5.   Market Revenue and Forecast, By Application (2016-2030)

13.3.13.6.   Market Revenue and Forecast, By End-use (2016-2030)

13.4.        MEA

13.4.1.  Market Revenue and Forecast, By Product (2016-2030)

13.4.2.  Market Revenue and Forecast, By Enzymes Source (2016-2030)

13.4.3.  Market Revenue and Forecast, By Enzymes Technique (2016-2030)

13.4.4.  Market Revenue and Forecast, By Usage (2016-2030)

13.4.5.  Market Revenue and Forecast, By Application (2016-2030)

13.4.6.  Market Revenue and Forecast, By End-use (2016-2030)

13.4.7.  GCC

13.4.7.1.      Market Revenue and Forecast, By Product (2016-2030)

13.4.7.2.      Market Revenue and Forecast, By Enzymes Source (2016-2030)

13.4.7.3.      Market Revenue and Forecast, By Enzymes Technique (2016-2030)

13.4.7.4.      Market Revenue and Forecast, By Usage (2016-2030)

13.4.8.  Market Revenue and Forecast, By Application (2016-2030)

13.4.9.  Market Revenue and Forecast, By End-use (2016-2030)

13.4.10.               North Africa

13.4.10.1.   Market Revenue and Forecast, By Product (2016-2030)

13.4.10.2.   Market Revenue and Forecast, By Enzymes Source (2016-2030)

13.4.10.3.   Market Revenue and Forecast, By Enzymes Technique (2016-2030)

13.4.10.4.   Market Revenue and Forecast, By Usage (2016-2030)

13.4.11.               Market Revenue and Forecast, By Application (2016-2030)

13.4.12.               Market Revenue and Forecast, By End-use (2016-2030)

13.4.13.               South Africa

13.4.13.1.   Market Revenue and Forecast, By Product (2016-2030)

13.4.13.2.   Market Revenue and Forecast, By Enzymes Source (2016-2030)

13.4.13.3.   Market Revenue and Forecast, By Enzymes Technique (2016-2030)

13.4.13.4.   Market Revenue and Forecast, By Usage (2016-2030)

13.4.13.5.   Market Revenue and Forecast, By Application (2016-2030)

13.4.13.6.   Market Revenue and Forecast, By End-use (2016-2030)

13.4.14.               Rest of MEA

13.4.14.1.   Market Revenue and Forecast, By Product (2016-2030)

13.4.14.2.   Market Revenue and Forecast, By Enzymes Source (2016-2030)

13.4.14.3.   Market Revenue and Forecast, By Enzymes Technique (2016-2030)

13.4.14.4.   Market Revenue and Forecast, By Usage (2016-2030)

13.4.14.5.   Market Revenue and Forecast, By Application (2016-2030)

13.4.14.6.   Market Revenue and Forecast, By End-use (2016-2030)

13.5.        Latin America

13.5.1.  Market Revenue and Forecast, By Product (2016-2030)

13.5.2.  Market Revenue and Forecast, By Enzymes Source (2016-2030)

13.5.3.  Market Revenue and Forecast, By Enzymes Technique (2016-2030)

13.5.4.  Market Revenue and Forecast, By Usage (2016-2030)

13.5.5.  Market Revenue and Forecast, By Application (2016-2030)

13.5.6.  Market Revenue and Forecast, By End-use (2016-2030)

13.5.7.  Brazil

13.5.7.1.      Market Revenue and Forecast, By Product (2016-2030)

13.5.7.2.      Market Revenue and Forecast, By Enzymes Source (2016-2030)

13.5.7.3.      Market Revenue and Forecast, By Enzymes Technique (2016-2030)

13.5.7.4.      Market Revenue and Forecast, By Usage (2016-2030)

13.5.8.  Market Revenue and Forecast, By Application (2016-2030)

13.5.8.1.      Market Revenue and Forecast, By End-use (2016-2030)

13.5.9.  Rest of LATAM

13.5.9.1.      Market Revenue and Forecast, By Product (2016-2030)

13.5.9.2.      Market Revenue and Forecast, By Enzymes Source (2016-2030)

13.5.9.3.      Market Revenue and Forecast, By Enzymes Technique (2016-2030)

13.5.9.4.      Market Revenue and Forecast, By Usage (2016-2030)

13.5.9.5.      Market Revenue and Forecast, By Application (2016-2030)

13.5.9.6.      Market Revenue and Forecast, By End-use (2016-2030)

Chapter 14.  Company Profiles

14.1.              Advanced Enzymes Technologies Ltd

14.1.1.  Company Overview

14.1.2.  Product Offerings

14.1.3.  Financial Performance

14.1.4.  Recent Initiatives

14.2.              Amano Enzymes, Inc.

14.2.1.  Company Overview

14.2.2.  Product Offerings

14.2.3.  Financial Performance

14.2.4.  Recent Initiatives

14.3.              Amicogen

14.3.1.  Company Overview

14.3.2.  Product Offerings

14.3.3.  Financial Performance

14.3.4.  Recent Initiatives

14.4.              BBI Solutions

14.4.1.  Company Overview

14.4.2.  Product Offerings

14.4.3.  Financial Performance

14.4.4.  Recent Initiatives

14.5.              biotechrabbit GmbH

14.5.1.  Company Overview

14.5.2.  Product Offerings

14.5.3.  Financial Performance

14.5.4.  Recent Initiatives

14.6.              Brain AG

14.6.1.  Company Overview

14.6.2.  Product Offerings

14.6.3.  Financial Performance

14.6.4.  Recent Initiatives

14.7.              CPC Biotech

14.7.1.  Company Overview

14.7.2.  Product Offerings

14.7.3.  Financial Performance

14.7.4.  Recent Initiatives

14.8.              Creative Enzymes

14.8.1.  Company Overview

14.8.2.  Product Offerings

14.8.3.  Financial Performance

14.8.4.  Recent Initiatives

14.9.              EKF Diagnostics.

14.9.1.  Company Overview

14.9.2.  Product Offerings

14.9.3.  Financial Performance

14.9.4.  Recent Initiatives

14.10.           F. Hoffmann-La Roche Ltd

14.10.1.               Company Overview

14.10.2.               Product Offerings

14.10.3.               Financial Performance

14.10.4.               Recent Initiatives

14.11.           Merck KGaA

14.11.1.               Company Overview

14.11.2.               Product Offerings

14.11.3.               Financial Performance

14.11.4.               Recent Initiatives

14.12.           Sekisui Chemical Co., Ltd.

14.12.1.               Company Overview

14.12.2.               Product Offerings

14.12.3.               Financial Performance

14.12.4.               Recent Initiatives

14.13.           Thermo Fisher Scientific, Inc.

14.13.1.               Company Overview

14.13.2.               Product Offerings

14.13.3.               Financial Performance

14.13.4.               Recent Initiatives

Chapter 15.  Research Methodology

15.1.              Primary Research

15.2.              Secondary Research

15.3.              Assumptions

Chapter 16.  Appendix

16.1.              About Us

Glossary of Terms